Breaking
European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
🇺🇸 FDA

Healthcare Access

Page 1 • 1 item

Gain critical insights into global pharmaceutical market access, pricing, reimbursement, and policy shifts impacting drug launches and patient affordability.

CMS and FDA Launch RAPID Coverage Pathway for Breakthrough Medical Devices Under Medicare
NewsMedical Devices - Multiple AreasApr 25, 2026

CMS and FDA Launch RAPID Coverage Pathway for Breakthrough Medical Devices Under Medicare

CMS and FDA announce RAPID coverage pathway to accelerate Medicare access to breakthrough medical devices, reducing coverage review delays for patients.

Dr. Laura Bennett